富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/17 | 1,371 | 1,375 | 1,358 | 1,361 | -14 | -1% | 113,900 |
| 2025/02/14 | 1,389 | 1,394 | 1,367 | 1,375 | -14 | -1% | 62,100 |
| 2025/02/13 | 1,395 | 1,404 | 1,383 | 1,389 | +6 | +0.4% | 92,400 |
| 2025/02/12 | 1,375 | 1,387 | 1,360 | 1,383 | +8 | +0.6% | 115,100 |
| 2025/02/10 | 1,383 | 1,412 | 1,375 | 1,375 | -5 | -0.4% | 192,700 |
| 2025/02/07 | 1,363 | 1,388 | 1,329 | 1,380 | -73 | -5% | 365,900 |
| 2025/02/06 | 1,421 | 1,468 | 1,415 | 1,453 | +36 | +2.5% | 122,100 |
| 2025/02/05 | 1,416 | 1,421 | 1,402 | 1,417 | -2 | -0.1% | 72,500 |
| 2025/02/04 | 1,439 | 1,454 | 1,415 | 1,419 | -8 | -0.6% | 89,000 |
| 2025/02/03 | 1,461 | 1,461 | 1,424 | 1,427 | -42 | -2.9% | 88,000 |
| 2025/01/31 | 1,488 | 1,488 | 1,468 | 1,469 | -22 | -1.5% | 39,100 |
| 2025/01/30 | 1,508 | 1,511 | 1,476 | 1,491 | -18 | -1.2% | 63,800 |
| 2025/01/29 | 1,507 | 1,519 | 1,502 | 1,509 | +2 | +0.1% | 88,600 |
| 2025/01/28 | 1,490 | 1,519 | 1,490 | 1,507 | +22 | +1.5% | 74,700 |
| 2025/01/27 | 1,498 | 1,518 | 1,485 | 1,485 | +10 | +0.7% | 47,300 |
| 2025/01/24 | 1,476 | 1,490 | 1,469 | 1,475 | +5 | +0.3% | 53,500 |
| 2025/01/23 | 1,478 | 1,482 | 1,452 | 1,470 | -33 | -2.2% | 84,400 |
| 2025/01/22 | 1,498 | 1,530 | 1,489 | 1,503 | +16 | +1.1% | 86,300 |
| 2025/01/21 | 1,526 | 1,529 | 1,481 | 1,487 | -35 | -2.3% | 56,800 |
| 2025/01/20 | 1,470 | 1,528 | 1,470 | 1,522 | +61 | +4.2% | 88,000 |
| 2025/01/17 | 1,486 | 1,486 | 1,451 | 1,461 | -25 | -1.7% | 39,800 |
| 2025/01/16 | 1,507 | 1,507 | 1,485 | 1,486 | -17 | -1.1% | 54,200 |
| 2025/01/15 | 1,525 | 1,541 | 1,497 | 1,503 | -27 | -1.8% | 62,000 |
| 2025/01/14 | 1,508 | 1,533 | 1,508 | 1,530 | +13 | +0.9% | 79,700 |
| 2025/01/10 | 1,540 | 1,541 | 1,507 | 1,517 | -43 | -2.8% | 95,900 |
| 2025/01/09 | 1,543 | 1,574 | 1,542 | 1,560 | +19 | +1.2% | 90,600 |
| 2025/01/08 | 1,570 | 1,575 | 1,534 | 1,541 | -22 | -1.4% | 88,500 |
| 2025/01/07 | 1,600 | 1,602 | 1,559 | 1,563 | -33 | -2.1% | 156,400 |
| 2025/01/06 | 1,604 | 1,606 | 1,596 | 1,596 | -3 | -0.2% | 82,200 |
| 2024/12/30 | 1,610 | 1,619 | 1,599 | 1,599 | -11 | -0.7% | 92,700 |
| 2024/12/27 | 1,581 | 1,615 | 1,581 | 1,610 | +29 | +1.8% | 137,300 |
| 2024/12/26 | 1,593 | 1,593 | 1,571 | 1,581 | -12 | -0.8% | 87,500 |
| 2024/12/25 | 1,613 | 1,613 | 1,574 | 1,593 | -18 | -1.1% | 95,800 |
| 2024/12/24 | 1,588 | 1,613 | 1,572 | 1,611 | +52 | +3.3% | 154,500 |
| 2024/12/23 | 1,547 | 1,569 | 1,538 | 1,559 | +10 | +0.6% | 91,600 |
| 2024/12/20 | 1,546 | 1,569 | 1,542 | 1,549 | +13 | +0.8% | 107,400 |
| 2024/12/19 | 1,514 | 1,558 | 1,510 | 1,536 | +4 | +0.3% | 82,300 |
| 2024/12/18 | 1,548 | 1,549 | 1,520 | 1,532 | -16 | -1% | 89,300 |
| 2024/12/17 | 1,552 | 1,557 | 1,541 | 1,548 | ±0 | ±0% | 124,000 |
| 2024/12/16 | 1,548 | 1,570 | 1,542 | 1,548 | +25 | +1.6% | 107,600 |
| 2024/12/13 | 1,528 | 1,537 | 1,510 | 1,523 | -5 | -0.3% | 103,100 |
| 2024/12/12 | 1,530 | 1,548 | 1,523 | 1,528 | -1 | -0.1% | 134,800 |
| 2024/12/11 | 1,527 | 1,542 | 1,520 | 1,529 | +4 | +0.3% | 79,500 |
| 2024/12/10 | 1,553 | 1,553 | 1,520 | 1,525 | -31 | -2% | 132,200 |
| 2024/12/09 | 1,560 | 1,572 | 1,551 | 1,556 | +6 | +0.4% | 88,100 |
| 2024/12/06 | 1,590 | 1,590 | 1,550 | 1,550 | -53 | -3.3% | 104,400 |
| 2024/12/05 | 1,590 | 1,611 | 1,587 | 1,603 | ±0 | ±0% | 161,900 |
| 2024/12/04 | 1,623 | 1,633 | 1,590 | 1,603 | -29 | -1.8% | 212,400 |
| 2024/12/03 | 1,634 | 1,640 | 1,595 | 1,632 | -3 | -0.2% | 170,300 |
| 2024/12/02 | 1,600 | 1,635 | 1,591 | 1,635 | +21 | +1.3% | 158,500 |
51～
100
件表示中 / 6944件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 135,700円 | +15.7% | +5.3% | 3.35% | 9.81倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| タウンズ | 50,500円 | +4.6% | +6.1% | 5.54% | 8.59倍 | 3.18倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 生化学 | 70,400円 | +9.2% | +39.0% | 4.26% | 23.29倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,000円 | +150.0% | - | 0.00% | - | 15.74倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 208,000円 | +4.5% | -33.7% | 3.37% | 20.95倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
市場注目の銘柄
チャート関連のコラム
